Cargando…

Photocatalytic Degradation of Dyes Using Titania Nanoparticles Supported in Metal-Organic Materials Based on Iron

Composite materials based on titania nanoparticles (TiO(2) NPs) and three metal-organic frameworks (MOFs) called MIL-53 (Fe) ((Fe (III) (OH) (1,4-BDC)), MILs (Materials Institute Lavoisier)), MIL-100 (Fe) (Fe(3)O(H(2)O)(2)OH(BTC)(2)), and Fe-BTC (iron-benzenetricarboxylate) with different percentage...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojas-García, Elizabeth, García-Martínez, Diana Carolina, López-Medina, Ricardo, Rubio-Marcos, Fernando, Castañeda-Ramírez, Aldo A., Maubert-Franco, Ana M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610564/
https://www.ncbi.nlm.nih.gov/pubmed/36296671
http://dx.doi.org/10.3390/molecules27207078
Descripción
Sumario:Composite materials based on titania nanoparticles (TiO(2) NPs) and three metal-organic frameworks (MOFs) called MIL-53 (Fe) ((Fe (III) (OH) (1,4-BDC)), MILs (Materials Institute Lavoisier)), MIL-100 (Fe) (Fe(3)O(H(2)O)(2)OH(BTC)(2)), and Fe-BTC (iron-benzenetricarboxylate) with different percentages of TiO(2) NPs (0.5, 1, and 2.5% wt.) were synthesized using the solvothermal method and used as photocatalytic materials in the degradation of two dyes (Orange II and Reactive Black 5 (RB5)). The pristine and composite materials were characterized with X-ray diffraction, Raman, UV–Vis and Fourier transform infrared spectroscopy and scanning electron microscopy techniques. The 2.5TiO(2)/MIL-100 composite material showed the best results for the degradation of both dyes (Reactive Black 5 and Orange II dye, 99% and 99.5% degradation in 105 and 150 min, respectively). The incorporation of TiO(2) NPs into MOFs can decrease the recombination of the change carrier in the MOF, increasing the photocatalytic activity of a pristine MOF. Results therefore indicated that the synthesized MOF nanocomposites have good potential for wastewater treatment.